Many approved cancer therapies target a protein called epidermal growth factor receptor (EGFR) that regulates many crucial cellular processes and can speed the proliferation of tumor cells. Yale Cancer Center scientists now have made a fundamental discovery about EGFR signaling … more

More than 20 years after scientists revealed that mutations in the BRCA1 gene predispose women to breast cancer, Yale scientists have pinpointed the molecular mechanism that allows those mutations to wreak their havoc … more

Thanks to a massive analysis of genes from 2,871 CHD patients and their families, a Yale researcher has uncovered links between congenital heart disease and conditions such as autism and respiratory disorders … more